IDE approval by the FDA marks a significant milestone in the global expansion of the i-SIGHT2 study, which is already actively enrolling and treating study participants in the United Kingdom, ...
IDRIJA, SLOVENIA, October 15, 2024 /EINPresswire.com/ -- AmblyoPlay, a leading innovator in vision therapy solutions, proudly announces the launch of its ...
Electrode arrays could help regenerate damaged optic nerves ...
The emergence of electrical brain activity as a possible therapeutic target has uncovered new insights into how Alzheimer’s develops and progresses. Cognito Therapeutics, a neurotechnology company led ...
Making sure a stovetop isn’t left on or readjusting an askew picture frame is often a natural response when something feels off. Yet, for over two million Americans living with obsessive-compulsive ...